133 CRISPR/Cas9 gene-edited allogeneic CAR-T cells targeting CD33 show high preclinical efficacy against AML without long-term hematopoietic toxicity
Jonathan Terrett, Demetrios Kalaitzidis(Harvard University), Daniel R. Hostetter(University of California, San Francisco), Luis Fernando Gamboa(University of Washington), Robert Chain, Meghna Kuppuraju, Zinkal Padalia, Mohammed G. Ghonime, Brigid McEwan
Cited by 0
Related Papers
Inequality of opportunity for educational achievement in Latin America: Evidence from PISA 2006–2009
|Economics of Education Review|2012|139
Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study
|Clinical Infectious Diseases|2022|80
Optical Imaging of Cellular Immunotherapy against Prostate Cancer
|Molecular Imaging|2009|67
Impacts of human mobility on the citywide transmission dynamics of 18 respiratory viruses in pre- and post-COVID-19 pandemic years
|Nature Communications|2024|55
SwabExpress: An end-to-end protocol for extraction-free COVID-19 testing
|bioRxiv (Cold Spring Harbor Laboratory)|2020|50